Drug combinations against Mucor irregularis in vitro.

about

Mucor irregularis-associated cutaneous mucormycosis: Case report and review.Evaluation of antifungal combination against Cryptococcus spp.Successful Treatment by Surgery of a Primary Cutaneous Mucormycosis Caused by Mucor irregularis.

P2860

Q34436174-E3149CB1-D44E-4D37-840B-29381766F681 Q46554956-8E40A769-C647-4829-AECD-9B4039FBFAA7 Q51769407-DA460A9A-6312-4617-AF53-9AF8A7E6AEED

P2860

Drug combinations against Mucor irregularis in vitro.

Item

http://www.wikidata.org/entity/Q36969929

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Drug combinations against Mucor irregularis in vitro.

@en

type

Item

label

Drug combinations against Mucor irregularis in vitro.

@en

prefLabel

Drug combinations against Mucor irregularis in vitro.

@en

P1476

Drug combinations against Mucor irregularis in vitro.

@en

P2093

Jin Yu

http://www.w3.org/2001/XMLSchema#string

Ruoyu Li

http://www.w3.org/2001/XMLSchema#string

Shuzhen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.

In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosis

Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India.

Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia

Primary cutaneous zygomycosis caused by rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China.

Terbinafine: a pharmacological and clinical review.

Posaconazole for the treatment of mucormycosis.

Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

P304

3395-3397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02612-12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23587956

http://www.w3.org/2001/XMLSchema#string

P932

3697376

http://www.w3.org/2001/XMLSchema#string

Drug combinations against Mucor irregularis in vitro.

about

P2860

P2860

Drug combinations against Mucor irregularis in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932